My site

 Leading Bangalore Hospital CEOs Convene for Masimo Roundtable

BANGALORE, India - Tuesday, January 3rd 2017 [ME NewsWire]

(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today the launch and availability of the Rad-97™ Pulse-CO Oximeter®* and Next Generation SedLine®* Brain Function Monitoring in India. The announcement was made in Bangalore by Joe Kiani, Founder and CEO of Masimo, at a roundtable of the CEOs of top Bangalore hospitals.

Joe Kiani, Founder and CEO, Masimo, commented, “The Indian healthcare sector recognizes the need for technologies that help their clinicians get the best results, the first time. Masimo’s noninvasive patient monitoring technology innovations offer capabilities that have never been possible before. With a large population and a burgeoning demand for an improved quality of life – including the safe, high-quality healthcare to which all are entitled – India continues to be a focus mark ... Read more »

- Both companies will become global leaders in two different sectors of the pharmaceutical market -

PARIS & INGELHEIM, Germany - Monday, January 2nd 2017 [ME NewsWire]

(BUSINESS WIRE)-- Sanofi and Boehringer Ingelheim confirmed today that the strategic transaction signed in June 2016, which consists of an exchange of Sanofi’s animal health business (Merial) and Boehringer Ingelheim’s consumer healthcare (CHC) business, has been successfully closed in most markets on January 1st 2017. This closing marks the successful outcome of the business swap which started with exclusive negotiations in December 2015. The closing of the acquisition of Merial in Mexico and the Merial and CHC swap in India have been delayed pending receipt of certain regulatory approvals but both are expected to close early 2017.

The Chairman of the Board of Managing Directors of Boehringer Ingelheim, Hubertus von Baumbach, said: “This important achievement is the resul ... Read more »